Anti-inflammatory effect of Sustained release granules of Aceclofenac in Gouty Arthritis Rat
- 30 November 2021
- journal article
- research article
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 14 (11) , 5729-5732
Abstract
Gout is most common painful clinical syndrome occurs due to hyperuricaemia (high serum uric acid level) and deposition of monosodium urate crystals in joints. In the current experimental study, the anti-inflammatory effect of sustained release granules of aceclofenac, was investigated on monosodium urate crystal-induced inflammation in rat. Monosodium urate is injected appropriately at a dose of 3 mg/kg body weight of a rat on right ankle to induce inflammation in joint like gouty arthritis. The percentage of joint swelling in positive control group was increased significantly (p<0.5) when compared with normal group after 1 hr, 12 hr and 24 hr with a single injection of MSU. Therapeutic effect of sustained released granules (OD) is similar to conventional released granules (BD) and possesses an anti-inflammatory effect, which could provide relief in gouty arthritis after administration of sustained release formulation of aceclofenac once in a day only. The current study clearly indicated that slow release granules of aceclofenac exerted a strong anti-inflammatory effect against gouty arthritis at standard dose once daily. It concluded that, when aceclofenac tablet is formulated with slow release granules it decreases the dosing frequency with same therapeutic effect.Keywords
This publication has 11 references indexed in Scilit:
- A Review on Gouty ArthritisResearch Journal of Pharmacy and Technology, 2019
- Efficacy of Cox-2 inhibitors in the Clinical Management of TMJ Arthritis: A ReviewResearch Journal of Pharmacy and Technology, 2017
- Simultaneous Formulation, Evaluation and estimation of controlled release of NSAID DrugAsian Journal of Pharmaceutical Analysis, 2017
- Comparative Study on Anti-inflammatory and Analgesic Activities of Pure Aceclofenac with the Aceclofenac Loaded Mucoadhesive Microparticles in RatsResearch Journal of Pharmacy and Technology, 2015
- Uric acid: A marker of increased cardiovascular riskAtherosclerosis, 2009
- PEG-uricase in the management of treatment-resistant gout and hyperuricemiaAdvanced Drug Delivery Reviews, 2008
- Metabolic diseases: goutClinics in Dermatology, 2006
- Clinical manifestations and treatment of goutPrimary Care Update for OB/GYNS, 2003
- AceclofenacDrugs, 2001
- Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch modelArthritis & Rheumatism, 1993